Rezolute

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Rezolute and other ETFs, options, and stocks.

About RZLT

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperinsulinism, AB101-Phase 1, a once-weekly injectable basal insulin, and RZ402, which targets diabetic macular edema. 

CEO
Nevan Charles Elam
CEONevan Charles Elam
Employees
42
Employees42
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2010
Founded2010
Employees
42
Employees42

RZLT Key Statistics

Market cap
112.60M
Market cap112.60M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
98.81K
Average volume98.81K
High today
$2.91
High today$2.91
Low today
$2.43
Low today$2.43
Open price
$2.44
Open price$2.44
Volume
7.11K
Volume7.11K
52 Week high
$8.56
52 Week high$8.56
52 Week low
$2.06
52 Week low$2.06

RZLT Earnings

-$0.92
-$0.61
-$0.31
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
-$0.41 per share
Estimated-$0.41 per share
Actual
-$0.37 per share
Actual-$0.37 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.